Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
11 current organization shown on this profile
Board positions
Not establishedNo board position is currently listed on this profile
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Has over 30 years of experience as a financial executive, approximately 25 of which are in the pharmaceutical industry, including roles at Par Pharmaceutical Companies and Schering-Plough Corporation. Began his career at PricewaterhouseCoopers and holds a B.S. in Accounting from Montclair State University.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Executive appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Connections

Explore the roles, education and affiliations published in this record.

ANI PHARMACEUTICALS INC

Open ANI PHARMACEUTICALS INC profile →

SVP & CFO at ANI PHARMACEUTICALS INC

Start not stated → End not stated

current · source reported

Observed: 2026-09-25

ANI PHARMACEUTICAL…ANI PHARMACEUTICALS INCStephen P. Carey

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec Form OwnershipPublic profile sourceSupports SVP & CFO at ANI PHARMACEUTICALS INC (NASDAQ: ANIP), Executive title.Open sourceSource 2 · Sec FilingANIP DEF 14A executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:stephen-p-carey-anip
Record version
public-0

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec form ownership · Source published: Jul 2, 2026 · Retrieved: Jul 29, 2026

    Supports 2 claims
    • Professional Role: SVP & CFO at ANI PHARMACEUTICALS INC · Claim reviewed: May 14, 2026
    • Executive title: Executive title: SVP & CFO · Claim reviewed: May 14, 2026

  2. ANIP DEF 14A executive officers

    sec filing · Source published: Apr 9, 2026 · Retrieved: May 14, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 14, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 14, 2026
    • Executive company: Executive at ANI PHARMACEUTICALS INC · Claim reviewed: May 14, 2026
    • Executive title: Executive title: Senior Vice President, Finance and Chief Financial Officer · Claim reviewed: May 14, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 14, 2026

  3. ANIP executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
    • Executive company: Executive at ANI PHARMACEUTICALS INC · Claim reviewed: May 14, 2026
    • Executive function: Finance Controls (CFO) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Senior Vice President, Finance and Chief Financial Officer · Claim reviewed: May 14, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 14, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 14, 2026

AI expertise · Source reportedAI expertise: not identified in the cited filing1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

AI governance relevance · Source reportedAI governance relevance: not identified in the cited filing1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 14, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 14, 2026

Executive company · CorroboratedExecutive at ANI PHARMACEUTICALS INCSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 14, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 14, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive function · Source reportedFinance Controls (CFO)1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · CorroboratedExecutive title: Senior Vice President, Finance and Chief Financial OfficerSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 14, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 14, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: SVP & CFO1 source
Verification
Source reported
Confidence
100%
Last reviewed
May 14, 2026
Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 14, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 14, 2026

View all sources3 records
  1. https://www.sec.gov/Archives/edgar/data/1023024/000167423626000017/wk-form4_1783388415.xml

    Sec Form Ownership · Tier not stated · Reviewed Jul 29, 2026

    Supports: SVP & CFO at ANI PHARMACEUTICALS INC (NASDAQ: ANIP) · Executive title

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 14, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: AI expertise · AI governance relevance · Executive company · Executive function · Executive title